We are live on ! Find out more
MGCD

MGC Diagnostics Corporation
MGCD

Delisted

MGCD was delisted on the 28th of December, 2017.

0 hedge funds and large institutions have $0 invested in MGC Diagnostics Corporation in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 120 (-12)

100% less capital invested

Capital invested by funds: $4.23M → $0 (-$4.23M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 12

Holders
Holders Change
-12
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
12
Calls
Puts
Net Calls
Net Calls Change

MGCD Hedge Fund Activity: Q1 2018 in Review

0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q1 2018, worth a combined $0 — down 100% from $4.23M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MGCD and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Kennedy Capital Management, exiting entirely with an estimated $2.53M sold.

  • 0 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q1 2018, down from 12 in Q4 2017.
  • Funds reported $0 of MGC Diagnostics Corporation stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new MGC Diagnostics Corporation positions in Q1 2018 and 12 closed out, a net change of -12 holders.
  • The largest MGC Diagnostics Corporation seller in Q1 2018 was Kennedy Capital Management, an estimated $2.53M sold.

Based on aggregated 13F filings for Q1 2018.